scispace - formally typeset
Journal ArticleDOI

Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors

TLDR
There is a growing understanding of viral, host and environmental factors influencing disease progression, which ultimately could improve the management of chronic hepatitis B.
About
This article is published in Journal of Hepatology.The article was published on 2008-02-01. It has received 1172 citations till now. The article focuses on the topics: HBeAg & Hepatitis B.

read more

Citations
More filters
Journal ArticleDOI

HIV/HBV coinfection in children and antiviral therapy

TL;DR: The current literature relevant to HIV/HBV coinfection in children, the options for treatment and highlights priorities for future research are summarized.
Journal ArticleDOI

Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.

TL;DR: New cut-off values for ALT together with HBV DNA levels proposed by AASLD and NIH consensus seem appropriate to characterize inactive carriers.
Journal ArticleDOI

Molecular epidemiology of chronic hepatitis B virus infection in Greece.

TL;DR: HBV genotypes, surface antigen (HBsAg) subtypes, and HBsAg “a” determinant mutations among patients infected chronically with HBV, were investigated and amino acid substitutions did not affect detection by commercial immunoassays.
Book

Refugee Health Care: An Essential Medical Guide

TL;DR: The role of national and local resettlement agencies, and recent trends in refugee arrivals, are summarized.
Journal ArticleDOI

Why actively promote vaccination in patients with cirrhosis

TL;DR: Few data regarding vaccination coverage are available, but studies suggest that immunization rates are too low in this population of patients with cirrhosis.
References
More filters
Journal ArticleDOI

Measuring inconsistency in meta-analyses

TL;DR: A new quantity is developed, I 2, which the authors believe gives a better measure of the consistency between trials in a meta-analysis, which is susceptible to the number of trials included in the meta- analysis.
Journal ArticleDOI

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

TL;DR: Elevated serum HBV DNA level (> or =10,000 copies/mL) is a strong risk predictor of hepatocellular carcinoma independent of HBeAg, serum alanine aminotransferase level, and liver cirrhosis.
Journal ArticleDOI

Chronic hepatitis B

TL;DR: These guidelines have been written to assist physicians and other health care providers in the recognition, diagnosis, and management of patients chronically infected with the hepatitis B virus (HBV).
Journal ArticleDOI

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

TL;DR: HBV and HCV infections account for the majority of cirrhosis and primary liver cancer throughout most of the world, highlighting the need for programs to prevent new infections and provide medical management and treatment for those already infected.
Journal ArticleDOI

Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

TL;DR: Further studies are needed to investigate other viral factors (eg, HBV genotype/mutant, occult HBV, HIV coinfection) and preventable or treatable comorbidities ( eg, obesity, diabetes) in the HCC risk in cirrhosis.
Related Papers (5)